Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EPZ020411 hydrochloride 是一种选择性的和有效的 PRMT6抑制剂,IC50=10 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 693 | 现货 | ||
5 mg | ¥ 1,650 | 现货 | ||
10 mg | ¥ 2,890 | 现货 | ||
25 mg | ¥ 4,290 | 现货 | ||
50 mg | ¥ 5,390 | 现货 | ||
100 mg | ¥ 7,670 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,820 | 现货 |
产品描述 | EPZ020411 hydrochloride is a selective and potent small molecule PRMT6 inhibitor with an IC50 value of 10 nM. |
靶点活性 | PRMT8:223 nM, PRMT1:119 nM, PRMT6:10 nM |
体外活性 | Treatment with EPZ020411 results in a dose-dependent decrease in H3R2 methylation in A375 human melanoma cells exogenously overexpressing PRMT6(IC50=0.637±0.241 μM). EPZ020411 is over 100-fold selective for PRMT6/8/1 compared to other histone methyltransferases including PRMT3, PRMT4, PRMT5, and PRMT7 in biochemical assays. The compound shows poor permeability in the parallel artificial membrane permeation assay[1]. |
体内活性 | EPZ020411 shows good bioavailability following subcutaneous dosing in rats. Male Sprague-Dawley rats administered EPZ020411 at a single dose of 1 mg/kg by i.v. bolus show a moderate clearance (CL) of 19.7±1.0 mL/min/kg, with a volume of distribution at steady state (Vss) of 11.1±1.6 L/kg, translating to a mean terminal half-life (t1/2) of 8.54±1.43 h. A good bioavailability of 65.6 ± 4.3% is observed following 5 mg/kg s.c. dosing, leading to EPZ020411 unbound blood concentration remaining above the PRMT6 biochemical IC50 for more than 12 h[1]. |
细胞实验 | Cell lines: A375 cells. Concentrations: 0-20 μM. Incubation Time: 48 h. Method: A375 (CRL-1619) cells are cultured in DMEM with 10% (vol/vol) FBS. PRMT6 is cloned into EcoRI and BamHI sites of a pcDNA4 HisMAX_A plasmid. According to procedures recommended by the manufacturer, transfection of his-tagged PRMT6 or vector control is carried out using Lipofectamine LTX and Plus reagent . Cells are seeded at 200,000 cells/well in 6-well plates. The second day, the cells are concurrently transfected and treated with compound in 0.25% DMSO. Cells are incubated in the presence compound at 20 μM and collected after 48 hours treatment. |
动物实验 | Animal Models: SD rats. Dosages: 1 mg/kg. Administration: i.v.. |
别名 | EPZ020411 HCl |
分子量 | 479.05 |
分子式 | C25H39ClN4O3 |
CAS No. | 2070015-25-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 18.0 mg/mL (37.6 mM), Sonication and heating to 60℃ are recommended.
DMSO: 45.0 mg/mL (93.9 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 2.0875 mL | 10.4373 mL | 20.8746 mL | 52.1866 mL |
5 mM | 0.4175 mL | 2.0875 mL | 4.1749 mL | 10.4373 mL | |
10 mM | 0.2087 mL | 1.0437 mL | 2.0875 mL | 5.2187 mL | |
20 mM | 0.1044 mL | 0.5219 mL | 1.0437 mL | 2.6093 mL | |
DMSO | 50 mM | 0.0417 mL | 0.2087 mL | 0.4175 mL | 1.0437 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
EPZ020411 hydrochloride 2070015-25-5 Chromatin/Epigenetic Histone Methyltransferase EPZ 020411 Hydrochloride EPZ-020411 hydrochloride EPZ020411 HCl EPZ020411 Hydrochloride EPZ-020411 Hydrochloride Inhibitor inhibitor inhibit